Humacyte FY2025 EPS Forecast Increased by Cantor Fitzgerald
Humacyte, Inc. (NASDAQ:HUMA – Free Report) – Research analysts at Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for Humacyte in a note issued to investors on Wednesday, April 23rd. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings of ($0.71) per share for the year, up from their […]
Humacyte, Inc. (NASDAQ:HUMA – Free Report) – Research analysts at Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for Humacyte in a note issued to investors on Wednesday, April 23rd. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings of ($0.71) per share for the year, up from their […]
